1-3 of 3
Ryoichi Takayanagi
Close
Sort by
Journal Articles

Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Junichi Kiyasu, Hiroaki Miyoshi, Akie Hirata, Fumiko Arakawa, Ayako Ichikawa, Daisuke Niino, Yasuo Sugita, Yuji Yufu, Ilseung Choi, Yasunobu Abe, Naokuni Uike, Koji Nagafuji, Takashi Okamura, Koichi Akashi, Ryoichi Takayanagi, Motoaki Shiratsuchi, Koichi Ohshima
Journal: Blood
Blood (2015) 126 (19): 2193–2201.
https://doi.org/10.1182/blood-2015-02-629600
Published: 2015
Includes: Supplemental data
Journal Articles

Vitamin K2 Modulates Differentiation and Apoptosis of Both Myeloid and Erythroid Lineages

Eriko Sada, Yasunobu Abe, Rie Ohba, Yoshimichi Tachikawa, Eriko Nagasawa, Shiratshuchi Motoaki, Ryoichi Takayanagi, Tsukuru Umemura, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 3993.
https://doi.org/10.1182/blood.V116.21.3993.3993
Published: 2010
Journal Articles

Differential requirement for DOCK2 in migration of plasmacytoid dendritic cells versus myeloid dendritic cells

Brief Report
Kazuhito Gotoh, Yoshihiko Tanaka, Akihiko Nishikimi, Ayumi Inayoshi, Munechika Enjoji, Ryoichi Takayanagi, Takehiko Sasazuki, Yoshinori Fukui
Journal: Blood
Blood (2008) 111 (6): 2973–2976.
https://doi.org/10.1182/blood-2007-09-112169
Published: 2008
Includes: Supplemental data